이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Carotid Decision Making

2026년 11월 12일 업데이트: Jesse.A.Columbo, Dartmouth-Hitchcock Medical Center

Improving Shared Decision Making for Older Patients With Carotid Artery Stenosis

Carotid artery stenosis is a common cause of ischemic stroke in the U.S. and disproportionately affects older adults. Patients with carotid artery stenosis face a complex set of decisions when choosing a treatment strategy. Patients must choose among surveillance with medical therapy alone, versus medical therapy plus one of three different procedures. Each treatment option has different levels of evidence to support it, some of which are decades old. Each procedural option has different expected periprocedural courses, different recoveries, and different cardiovascular risks. This challenging decision is amplified among older adults, where decisional values are often different from younger patients traditionally studied in randomized or observational studies. A decision aid could assist patients and providers who are navigating this decision, but no decision aid currently exists that includes all the contemporary carotid artery stenosis treatment options. In addition, as of October 2023, participation in a shared decision-making conversation is a Medicare-mandated component of carotid stenosis care, with reimbursement for procedures predicated on the documentation of the conversation with the patient.

The objective of this project is to conduct a single arm open label trial to test the feasibility of using a paper-based decision aid for patients considering carotid revascularization. The investigators will conduct a feasibility trial using the decision aid on older adults who are considering carotid revascularization. The investigators will recruit 50 participants aged 65 or older from the vascular surgery clinic and administer the decision aid. The investigators will purposively sample at least 10 participants that are age 80 or older. Primary outcomes will center on feasibility, and secondary outcomes will center on decisional conflict and regret.

연구 개요

상태

아직 모집하지 않음

정황

개입 / 치료

상세 설명

The primary outcomes of this single arm open label feasibility trial are focused on feasibility, and the secondary outcomes will provide data to inform a subsequent R01 study design.

Exposure: The decision aid

Setting: The investigators will sample newly referred and longitudinally treated patients from the Dartmouth Health Vascular Clinic who are being treated for carotid artery stenosis and who are considering carotid revascularization.

Sampling strategy: The investigators will enroll 50 patient-participants. The investigators will review the clinic schedules of the 18 providers each day in clinic and screen them for patients being seen for carotid artery stenosis. The investigators will then discuss with the providers in clinic that day whether any of the patients they are seeing may be considered for carotid revascularization and whether that respective patient would be appropriate for and have the capacity to utilize a decision aid. The investigators will purposively sample a minimum of 10 participants who are aged 80 and older to ensure adequate representation of this age group. Patients with carotid stenosis routinely have a high burden of comorbidities including hypertension, diabetes, coronary disease, kidney disease, and smoking. Patients treated in the Dartmouth Vascular Clinic are representative of this population and will allow us to sample a cohort with multiple comorbidities. Patients meeting the inclusion and exclusion criteria and felt to be appropriate for a decision aid per their treating provider will be approached in clinic to discuss the study.

Statistical analysis:

Outcome 1: The investigators will measure the mean and standard deviation of the time of the clinic visit. The investigators will calculate the visit time from the time of patient check in until the completion of the clinic visit, as assessed by a direct observer. The investigators will compare this to baseline time measurements recorded in the electronic health record for a random sample of 50 carotid stenosis patients meeting the same inclusion / exclusion criteria in the past 3 months.

Outcome 2: The investigators will conduct semi-structured interviews with 10 patients to follow up on the findings from the surveys above. These will be semi-structured interviews that are designed to assess whether the tradeoffs for each decision aid option were understood, and whether they felt that the decision aid helped them reach their choice. The interviews will be recorded and transcribed. The constant comparative method will be used to identify codes inductively. Two independent coders will analyze the data, and then codes will be discussed and data organized. Areas of disagreement will be resolved by consensus, or, if consensus is not possible, by a third independent reviewer. The investigators will organize the codes into key domains through data reduction and interpretation, paying particular attention to the frequency of specific ideas / codes mentioned by participants, and how many participants mentioned them.

The investigators will administer a similar survey to their treating providers within 1 week of the clinic visit. The results of the Likert surveys will be converted to a 5-point scale and the mean and median response will be computed with 95% confidence intervals. The investigators will additionally conduct semi-structured interviews with treating providers to determine feasibility of decision aid use in routine practice.

Secondary outcomes: The investigators will administer a validated decisional conflict scale and decisional regret scale before and after administration of the decision aid. The investigators will use the low literacy version to account for the high prevalence of low literacy in older adults. The investigators will analyze the results according to the validated methods for that survey and compare the before and after results. The investigators will additionally measure the actual treatment decision made by the patient and report this unadjusted. The investigators will finally measure knowledge-based questions that will be administered before and after patients are given the decision aid.

Sample size considerations: For outcome 1, given a sample size of 50 normally distributed outcomes, this will result in sample size with 95% confidence intervals with half widths of 0.32 standard deviation of the matched visit estimates of added time for increasing to 0.34, and 0.36 with 10% and 20% missing data. Similar results hold for the Likert survey in Outcome 3.

Potential pitfalls and alternative strategies: It is possible that it may not be known whether a patient would benefit from a decision aid until the patient receives an imaging study demonstrating the severity of the patient's carotid disease, which may occur just before the patient's clinic visit. Therefore, for patients who are scheduled for a clinic visit but do not have an imaging study, the investigators will ask the vascular laboratory (where the studies are conducted) to notify study personnel once the imaging study is completed.

연구 유형

중재적

등록 (추정된)

50

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • New Hampshire
      • Lebanon, New Hampshire, 미국, 03766
        • Dartmouth Hitchcock Medical Center

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

65년 이상 (고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Patients seen in the outpatient clinic who are considering carotid revascularization versus medical therapy or who were admitted to the hospital and are considering elective carotid revascularization.

Exclusion Criteria:

  • Patients who are considering urgent revascularization, those unable to provide informed consent using the Short Portable Mental Status Questionnaire or those unable to participate in follow-up interview or survey scales due to cognitive reasons.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Decision aid feasibility

Single arm pilot feasibility study of using a decision aid for patients with asymptomatic carotid artery stenosis considering revascularization

The decision aid is paper-based and includes pie charts of perioperative risks and incorporates patient values and preferences about autonomy of decision making.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Time to administer the decision aid
기간: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

Defined as time from clinic check-in until completion of the visit

Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)
Understanding of the decision aid
기간: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

Measured by a knowledge survey

Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

2차 결과 측정

결과 측정
측정값 설명
기간
Decisional conflict
기간: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

Measured using the validated decisional conflict scale

Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)
Decisional regret
기간: Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)

Measured using the validated decisional regret scale

Assessed for up to 2 weeks, from first clinic appointment until the end of the study (5/15/28)
Actual treatment decision made
기간: Assessed for up to 8 weeks

What treatment the patient actually decided on

Assessed for up to 8 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 15일

기본 완료 (추정된)

2028년 5월 15일

연구 완료 (추정된)

2028년 5월 15일

연구 등록 날짜

최초 제출

2026년 11월 2일

QC 기준을 충족하는 최초 제출

2026년 11월 12일

처음 게시됨 (실제)

2026년 11월 17일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 12일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • STUDY02001378
  • 1P20GM161873 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Will not share individual patient data due to confidentiality.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .